# EDGAR Filing Document

**Accession Number:** 0001435064
**File Stem:** 0001493152-23-004900
**Filing Date:** 2023-2
**Character Count:** 104082
**Document Hash:** b0dbf3bdef2435747377fdf348a09cd4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-004900.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001493152-23-004900

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 80

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CEMTREX INC
- **CENTRAL INDEX KEY:** 0001435064
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC COMPONENTS & ACCESSORIES [3670]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37464
- **FILM NUMBER:** 23629555

**BUSINESS ADDRESS:**
- **STREET 1:** 276 GREENPOINT AVE. BLD 8 SUITE 208
- **CITY:** BROOKLYN
- **STATE:** NY
- **ZIP:** 11222
- **BUSINESS PHONE:** 631 756 9116

**MAIL ADDRESS:**
- **STREET 1:** 276 GREENPOINT AVE. BLD 8 SUITE 208
- **CITY:** BROOKLYN
- **STATE:** NY
- **ZIP:** 11222

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM 10-Q** 

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934** 

For the quarterly period ended December 31, 2022

OR

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934**

For the transition period from ___________to ____________

**Commission File Number** 001-37464

![](form10-q_001.jpg)

**CEMTREX, INC.**

(Exact name of registrant as specified in its charter)

Delaware 30-0399914 <br> (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

276 Greenpoint Ave, Suite 208, Brooklyn, NY 11222 <br> (Address of principal executive offices) (Zip Code)

631-756-9116

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol** | **Name of each exchange on which registered** |
| Common Stock | CETX | Nasdaq Capital Market |
| Series 1 Preferred Stock | CETXP | Nasdaq Capital Market |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

**☒** Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

**☒** Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | |
|:---|:---|
| Large accelerated filer ☐ | Accelerated filer ☐ |
| Non-accelerated filer **☒** | Smaller reporting company **☒** |
|  | Emerging growth company ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

---

| | | | |
|:---|:---|:---|:---|
| ☐ | Yes | ☒ | No |

---

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

As of February 10, 2023, the issuer had 824,568 shares of common stock issued and outstanding.

**Table of Contents**

**CEMTREX, INC. AND SUBSIDIARIES**

INDEX

---

| | |
|:---|:---|
|  | Page |
| [**PART I. FINANCIAL INFORMATION**](#a_001) |  |
| [Item 1. Financial Statements](#a_002) |  |
| [Condensed Consolidated Balance Sheets as of December 31, 2022 (Unaudited) and September 30, 2022](#a_003) | 3 |
| [Condensed Consolidated Statements of Operations for the three months ended December 31, 2022 and December 31, 2021 (Unaudited)](#a_004) | 4 |
| [Condensed Consolidated Statements of Comprehensive Income/(Loss) for the three months ended December 31, 2022 and December 31, 2021 (Unaudited)](#a_005) | 5 |
| [Condensed Consolidated Statement of Stockholders' Equity for the three months ended December 31, 2022 (Unaudited)](#a_006) | 6 |
| [Condensed Consolidated Statement of Stockholders' Equity for the three months ended December 31, 2021 (Unaudited)](#a_007) | 7 |
| [Condensed Consolidated Statements of Cash Flow for the three months ended December 31, 2022 and December 31, 2021 (Unaudited)](#a_008) | 8 |
| [Notes to Unaudited Condensed Consolidated Financial Statements](#a_009) | 10 |
| [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_010) | 24 |
| [Item 4. Controls and Procedures](#a_011) | 28 |
| [**PART II. OTHER INFORMATION**](#a_012) |  |
| [Item 1. Legal Proceedings](#a_013) | 29 |
| [Item 1A Risk Factors](#a_014) | 29 |
| [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#a_015) | 29 |
| [Item 6. Exhibits](#a_016) | 30 |
| [**SIGNATURES**](#a_017) | 31 |

---

**<u>Part I. Financial Information</u>**

**Item 1. Financial Statements** 

**Cemtrex, Inc. and Subsidiaries**

**Condensed Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
|  | **(Unaudited)**<br>**December 31,**<br>**2022** |<br>**September 30,**<br>**2022** |
| **Assets** |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;Cash and equivalents | $5768610 | $9895761 |
| &nbsp;&nbsp;&nbsp;Restricted cash | 1601723 | 1577915 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 13721 | 13721 |
| &nbsp;&nbsp;&nbsp;Trade receivables, net | 6936077 | 5399216 |
| &nbsp;&nbsp;&nbsp;Trade receivables - related party | 383710 |  |
| &nbsp;&nbsp;&nbsp;Inventory –net of allowance for inventory obsolescence | 8604759 | 8487817 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | 3092618 | 2421644 |
| &nbsp;&nbsp;&nbsp;Assets of discontinued operations | - | 3971693 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 26401218 | 31767767 |
| Property and equipment, net | 5108267 | 5280442 |
| Right-of-use assets | 2520506 | 2641198 |
| Royalties receivable - related party | 665048 |  |
| Note receivable - related party | 761585 | 761585 |
| Goodwill | 3906891 | 3906891 |
| Other | 1546101 | 1399745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Assets** | $**40909616** | $**45757628** |
| **Liabilities & Stockholders' Equity (Deficit)** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $2722992 | $3050937 |
| &nbsp;&nbsp;&nbsp;Accounts payable - related party | 19034 | 19133 |
| &nbsp;&nbsp;&nbsp;Short-term liabilities | 17099485 | 16894743 |
| &nbsp;&nbsp;&nbsp;Lease liabilities - short-term | 787561 | 754495 |
| &nbsp;&nbsp;&nbsp;Deposits from customers | 489669 | 73146 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 3246129 | 2271188 |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 2505618 | 1551088 |
| &nbsp;&nbsp;&nbsp;Accrued income taxes |  | 94848 |
| &nbsp;&nbsp;&nbsp;Liabilities of discontinued operations | - | 805219 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 26870488 | 25514797 |
| Long-term liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Loans payable to bank | 92010 | 110331 |
| &nbsp;&nbsp;&nbsp;Long-term lease liabilities | 1732945 | 1822468 |
| &nbsp;&nbsp;&nbsp;Mortgage payable | 2142662 | 2160169 |
| &nbsp;&nbsp;&nbsp;Other long-term liabilities | 582392 | 807898 |
| &nbsp;&nbsp;&nbsp;Paycheck Protection Program Loans | 97120 | 97120 |
| &nbsp;&nbsp;&nbsp;Deferred Revenue - long-term | 595281 | 607309 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | 5242410 | 5605295 |
| Total liabilities | 32112898 | 31120092 |
| Commitments and contingencies |  |  |
| Shareholders' equity |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock , $0.001 par value, 10,000,000 shares authorized, Series 1, 3,000,000 shares authorized, 2,183,463 shares issued and 2,119,363 shares outstanding as of December 31, 2022 and 2,079,122 shares issued and 2,015,022 shares outstanding as of September 30, 2022 (liquidation value of $10 per share) | 2183 | 2079 |
| &nbsp;&nbsp;&nbsp;Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at December 31, 2022 and September 30, 2022 | 50 | 50 |
| &nbsp;&nbsp;&nbsp;Common stock, $0.001 par value, 50,000,000 shares authorized, 793,727 shares issued and outstanding at December 31, 2022 and 754,711 shares issued and outstanding at September 30, 2022 | 794 | 755 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 66913540 | 66641696 |
| &nbsp;&nbsp;&nbsp;Retained earnings (accumulated deficit) | (61206231) | (54929020) |
| &nbsp;&nbsp;&nbsp;Treasury stock, 64,100 shares of Series 1 Preferred Stock at December 31, 2022 and September 30, 2022 | (148291) | (148291) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss) | 2601094 | 2377525 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Cemtrex stockholders' equity | 8163139 | 13944794 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interest | 633579 | 692742 |
| **Total liabilities and shareholders' equity** | $**40909616** | $**45757628** |

---

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

**Cemtrex, Inc. and Subsidiaries**

**Condensed Consolidated Statements of Operations** 

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | For the three months ended | For the three months ended |
|  | December 31, 2022 | December 31, 2021 |
| Revenues | $11970242 | $9413395 |
| Cost of revenues | 6927627 | 6191145 |
| &nbsp;&nbsp;&nbsp;Gross profit | 5042615 | 3222250 |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative | 5455833 | 5447951 |
| &nbsp;&nbsp;&nbsp;Research and development | 1538218 | 1072898 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 6994051 | 6520849 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating loss | (1951436) | (3298599) |
| Other income/(expense) |  |  |
| &nbsp;&nbsp;&nbsp;Other income | (17083) | 930138 |
| &nbsp;&nbsp;&nbsp;Interest Expense | (1128234) | (1402404) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income/(expense), net | (1145317) | (472266) |
| Net loss before income taxes | (3096753) | (3770865) |
| &nbsp;&nbsp;&nbsp;Income tax benefit/(expense) | - | - |
| Loss from Continuing operations | (3096753) | (3770865) |
| Loss from discontinued operations, net of tax | (3239621) | (758958) |
| Net loss | (6336374) | (4529823) |
| Less loss in noncontrolling interest | (59163) | (51872) |
| &nbsp;&nbsp;&nbsp;**Net loss attributable to Cemtrex, Inc. shareholders** | $**(6277211)** | $**(4477951)** |
| Loss Per Share-Basic & Diluted |  |  |
| &nbsp;&nbsp;&nbsp;Continuing Operations | $(3.99) | $(5.64) |
| &nbsp;&nbsp;&nbsp;Discontinued Operations | $(4.25) | $(1.15) |
| Weighted Average Number of Shares-Basic & Diluted | 761571 | 659919 |

---

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

**Condensed Consolidated Statements Comprehensive Income/(Loss)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | For the three months ended | For the three months ended |
|  | December 31, 2022 | December 31, 2021 |
| Other comprehensive income/(loss) |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(6336374) | $(4529823) |
| &nbsp;&nbsp;&nbsp;Foreign currency translation (loss)/income | 223569 | 59492 |
| &nbsp;&nbsp;&nbsp;Comprehensive loss | (6112805) | (4470331) |
| &nbsp;&nbsp;&nbsp;Less comprehensive loss attributable to noncontrolling interest | (59163) | (51872) |
| Comprehensive loss attributable to Cemtrex, Inc. shareholders | $(6053642) | $(4418459) |

---

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

**Cemtrex, Inc. and Subsidiaries**

**Condensed Consolidated Statement of Stockholders' Equity** 

**(Unaudited)**

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Preferred Stock Series 1 | Preferred Stock Series 1 | Preferred Stock Series C | Preferred Stock Series C | Common Stock Par | Common Stock Par | | | | | | |
|  | Par Value $0.001 | Par Value $0.001 | Par Value $0.001 | Par Value $0.001 | Value $0.001 | Value $0.001 | | | | | | |
|  | Number of<br>Shares |<br>Amount | Number of<br>Shares |<br>Amount | Number of<br>Shares |<br>Amount |<br><br>Additional<br>Paid-in<br>Capital |<br>Retained<br>Earnings<br>(Accumulated<br>Deficit) | Treasury<br>Stock,<br>64,100 shares of <br>Series 1<br>Preferred<br>Stock |<br>Accumulated<br>other<br>Comprehensive<br>Income(loss) |<br><br>Cemtrex<br>Stockholders'<br>Equity |<br><br>Non-<br>controlling<br>interest |
| **Balance at September 30, 2022** | **2079122** | $**2079** | **&nbsp;&nbsp;&nbsp;&nbsp; 50000** | $**50** | **&nbsp;&nbsp;&nbsp;&nbsp;754711** | $**755** | $**66641696** | $**(54929020)** | $**(148291)** | $**2377525** | $**&nbsp;&nbsp;&nbsp;&nbsp;13944794** | $**692742** |
| Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  | 223569 | 223569 |  |
| Share-based compensation |  |  |  |  |  |  | 39842 |  |  |  | 39842 |  |
| Shares issued to pay notes payable |  |  |  |  | 39016 | 39 | 232106 |  |  |  | 232145 |  |
| Dividends paid in Series 1 preferred shares | 104341 | 104 |  |  |  |  | (104) |  |  |  |  |  |
| Income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  | (59163) |
| Net loss |  |  |  |  |  |  |  | (6277211) |  |  | (6277211) |  |
| **Balance at December 31, 2022** | **2183463** | $**2183** | **50000** | $**50** | **793727** | $**794** | $**66913540** | $**(61206231)** | $**(148291)** | $**2601094** | $**8163139** | $**633579** |

---

 ****

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

**Cemtrex, Inc. and Subsidiaries**

**Condensed Consolidated Statement of Stockholders' Equity (Continued)**

**(Unaudited)**

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Preferred Stock Series 1 | Preferred Stock Series 1 | Preferred Stock Series C | Preferred Stock Series C | Common Stock Par | Common Stock Par | | | | | | |
|  | Par Value $0.001 | Par Value $0.001 | Par Value $0.001 | Par Value $0.001 | Value $0.001 | Value $0.001 | | | | | | |
|  | Number of<br>Shares |<br>Amount | Number of<br>Shares |<br>Amount | Number of<br>Shares |<br>Amount |<br><br>Additional<br>Paid-in<br>Capital |<br>Retained<br>Earnings<br>(Accumulated<br>Deficit) | Treasury<br>Stock,<br>64,100 shares of<br>Series 1<br>Preferred<br>Stock |<br>Accumulated<br>other<br>Comprehensive<br>Income(loss) |<br><br>Cemtrex<br>Stockholders'<br>Equity |<br><br>Non-<br>controlling<br>interest |
| **Balance at September 30, 2021** | **1885151** | $**1885** | **&nbsp;&nbsp;&nbsp;&nbsp; 50000** | $**50** | **&nbsp;&nbsp;&nbsp;&nbsp;593777** | $**594** | $**61748022** | $**(41908062)** | $**(148291)** | $**2896452** | $**22590650** | $**964026** |
| Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  | 59492 | 59492 |  |
| Share-based compensation |  |  |  |  |  |  | 45371 |  |  |  | 45371 |  |
| Shares issued to pay notes payable |  |  |  |  | 82600 | 83 | 3287988 |  |  |  | 3288071 |  |
| Dividends paid in Series 1 preferred shares | 94602 | 95 |  |  |  |  | (95) |  |  |  |  |  |
| Income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  | (51872) |
| Net loss |  |  |  |  |  |  |  | (4477951) |  |  | (4477951) |  |
| **Balance at December 31, 2021** | **1979753** | $**1980** | **50000** | $**50** | **676377** | $**677** | $**65081286** | $**(46386013)** | $**(148291)** | $**2955944** | $**21505633** | $**912154** |

---

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

**Cemtrex, Inc. and Subsidiaries**

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | <br>**December 31,** | <br>**December 31,** |
|  | **2022** | **2021** |
| **Cash Flows from Operating Activities** |  |  |
| Net loss | $(6336374) | $(4529823) |
| Adjustments to reconcile net income/(loss) to net cash used by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 530830 | 247704 |
| &nbsp;&nbsp;&nbsp;(Gain)/loss on disposal of property and equipment | (3547) | 27170 |
| &nbsp;&nbsp;&nbsp;Noncash lease expense | 197198 | 196572 |
| &nbsp;&nbsp;&nbsp;Change in allowance for doubtful accounts | 4510 | 94588 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 39842 | 45371 |
| &nbsp;&nbsp;&nbsp;Interest expense paid in equity shares | 32145 | 821592 |
| &nbsp;&nbsp;&nbsp;Accrued interest on notes payable | 528100 | 132162 |
| &nbsp;&nbsp;&nbsp;Amortization of original issue discounts on notes payable | 441734 | 325000 |
| &nbsp;&nbsp;&nbsp;Gain on marketable securities |  | 21 |
| &nbsp;&nbsp;&nbsp;Discharge of Paycheck Protection Program Loans |  | (971500) |
| Changes in operating assets and liabilities net of effects from acquisition of subsidiaries: |  |  |
| &nbsp;&nbsp;&nbsp;Trade receivables | (1541371) | 2094282 |
| &nbsp;&nbsp;&nbsp;Trade receivables - related party | (383710) | (5166) |
| &nbsp;&nbsp;&nbsp;Inventory | (116942) | (1458595) |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (670974) | (144745) |
| &nbsp;&nbsp;&nbsp;Other assets | (146356) | (384) |
| &nbsp;&nbsp;&nbsp;Other liabilities | (225506) | (88266) |
| &nbsp;&nbsp;&nbsp;Accounts payable | (327945) | (726226) |
| &nbsp;&nbsp;&nbsp;Accounts payable - related party | (99) |  |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | (132963) | (104644) |
| &nbsp;&nbsp;&nbsp;Deposits from customers | 416523 | 205855 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 974941 | (142307) |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 942502 | (286261) |
| &nbsp;&nbsp;&nbsp;Income taxes payable | (94848) | (124823) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used by operating activities - continuing operations | (5872310) | (3633465) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided/(used) by operating activities - discontinued operations | 2501426 | (719237) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used by operating activities** | **(3370884)** | **(4352702)** |
| **Cash Flows from Investing Activities** |  |  |
| Purchase of property and equipment | (571658) | (301327) |
| Proceeds from sale of property and equipment | 3547 | 9661 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used by investing activities - continuing operations | (568111) | (291666) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by investing activities - discontinued operations | 207329 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided/(used) by investing activities** | **(360782)** | **(291666)** |
| **Cash Flows from Financing Activities** |  |  |
| Payments on notes payable | (294370) | (326763) |
| Payments on bank loans | (306550) | (305990) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used by financing activities** | **(600920)** | **(632753)** |
| Effect of currency translation | 229243 | 63228 |
| Net decrease in cash, cash equivalents, and restricted cash | (4332586) | (5277121) |
| Cash, cash equivalents, and restricted cash at beginning of period | 11473676 | 17186323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Cash, cash equivalents, and restricted cash at end of period** | $**7370333** | $**11972430** |
| **Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash** |  |  |
| &nbsp;&nbsp;&nbsp;Cash and equivalents | $5768610 | $10338978 |
| &nbsp;&nbsp;&nbsp;Restricted cash | 1601723 | 1633452 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total cash, cash equivalents, and restricted cash** | $**7370333** | $**11972430** |

---

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

 ****

**Cemtrex, Inc. and Subsidiaries**

**Condensed Consolidated Statements of Cash Flows (Continued)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| **Supplemental Disclosure of Cash Flow Information:** | | |
| Cash paid during the period for interest | $126255 | $126715 |
| Cash paid during the period for income taxes | $94848 | $124823 |
| **Supplemental Schedule of Non-Cash Investing and Financing Activities** |  |  |
| Shares issued to pay notes payable | $232145 | $3288071 |
| Investment in right of use asset | $76506 | $- |

---

***The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.***

**Cemtrex Inc. and Subsidiaries**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Unaudited)

NOTE 1 – ORGANIZATION AND PLAN OF OPERATIONS

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. The Company currently operates in two areas: industrial services, and intelligent security systems. Unless the context requires otherwise, all references to "we", "our", "us", "Company", "registrant", "Cemtrex" or "management" refer to Cemtrex, Inc. and its subsidiaries.

During the first quarter of fiscal year 2023, The Company reorganized its reporting segments to be in line with its current structure. The Company now has three business segments, consisting of (i) Security (ii) Industrial Services and (iii) Cemtrex Corporate.

*Security* 

Cemtrex's Security segment operates under the Vicon Industries brand. Vicon Industries, Inc. ("Vicon"), a majority owned subsidiary, provides end-to-end security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon's products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

*Industrial Services* 

Cemtrex's Industrial Services segment operates under the brand, Advanced Industrial Services ("AIS"), that offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. We are a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

*Cemtrex Corporate* 

Cemtrex's Corporate segment is the holding company of our other two segments.

*Sale of former Cemtrex Brands*

 

On November 22, 2022, the Company entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity ("SAFE") with the Company's CEO, Saagar Govil, to secure the sale of the subsidiaries Cemtrex Advanced Technologies, Inc, which include the brand SmartDesk, and Cemtrex XR, Inc., which include the brands Cemtrex XR, Virtual Driver Interactive, Bravo Strong, and good tech (formerly Cemtrex Labs), to Mr. Govil.

On November 22, 2022, the Company completed the above disposition for the following consideration.

● Cemtrex XR, Inc.

○ $895,000 comprised of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ $75,000 in cash payable at Closing; and

▪ 5 %
 royalty of all revenues on the Business to be paid 90 days after the end of each calendar
 year for the next three years; and should the total sum of royalties due be less than $820,000 at the end of the three-year period, Purchaser shall be obligated to pay the difference between
 $820,000 and the royalties paid.

● Cemtrex Advanced Technologies, Inc.

○ $10,000 in cash payable at Closing; and

○ 5 % royalty of all revenues on the Business to be paid 90 days after the end of each calendar year for the next 5 years ; and

○ $1,600,000 in SAFE (common equity) at any subsequent fundraising or exit above $5M with a $10M cap.

The Company's Board of Directors, excluding Saagar Govil who abstained from all voting on these agreements, approved these actions and agreements.

*Reverse Stock Split*

 

On January 25, 2023, the company completed a 35:1 reverse stock split on its common stock. All share and per share data have been retroactively adjusted for this reverse split.

*Extension of cure period*

 

On January 26, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that, it had been granted an additional 180 days or until July 24, 2023, to regain compliance with the Minimum Bid Price Requirement on its Series 1 Preferred stock.

*Listing Rule Compliance*

On February 8, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that it has regained compliance with Listing Rule 5550(a)(2) and is in compliance with all applicable listing standards. The Company's common stock will continue to be listed and traded on The Nasdaq Stock Market. The hearing scheduled for March 16, 2023 before the Hearings Panel has been cancelled.

*Going Concern Considerations*

 

The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of the ASC 205, management must evaluate whether there are conditions or events, considered in the aggregate, which raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these financial statements are issued.

This evaluation does not take into consideration the potential mitigating effect of management's plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company's ability to continue as a going concern. The mitigating effect of management's plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued.

The Company has incurred substantial losses of $13,020,958 and $7,807,995 for fiscal years 2022 and 2021, respectively, and has losses on continuing operations for the first quarter of fiscal year 2023 of $3,096,753 and has debt obligations over the next year of $17,099,485 and working capital deficit of $469,270, that raise substantial doubt with respect to the Company's ability to continue as a going concern.

While our working capital deficit and current debt indicate a substantial doubt regarding the Company's ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. Additionally, the Company has sold unprofitable brands, reducing the cash required to maintain those brands, reevaluated our pricing model on our Vicon brand to improve margins on those products, and has effected a 35:1 reverse stock split on our common stock to remain trading on the Nasdaq Capital Markets, and improve our ability to potentially raise capital through equity offerings that we may use to satisfy debt. In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans are sufficient to meet the capital demands of our current operations for at least the next twelve months, the is no guarantee that we will succeed. Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. We currently do not have adequate cash to meet our short or long-term needs. The condensed consolidated financial statements do not include any adjustments relating to this uncertainty.

NOTE 2 – INTERIM STATEMENT PRESENTATION

**Basis of Presentation and Use of Estimates**

The accompanying unaudited condensed consolidated financial information should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the year ended September 30, 2022, of Cemtrex Inc.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the Unites States ("US GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X pursuant to the requirements of the U.S. Securities and Exchange Commission ('SEC"). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.

The condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, Cemtrex Technologies Pvt. Ltd., Advanced Industrial Services, Inc., and the Company's majority owned subsidiary Vicon Industries, Inc. and its subsidiary, Vicon Industries Ltd. All inter-company balances and transactions have been eliminated in consolidation.

**Accounting Pronouncements**

Significant Accounting Policies

Note 2 of the Notes to Consolidated Financial Statements, included in the annual report on Form 10-K for the year ended September 30, 2022, includes a summary of the significant accounting policies used in the preparation of the consolidated financial statements.

Recently Issued Accounting Standards

In October 2021, the FASB issued ASU 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ("ASU No. 2021-08"). ASU No. 2021-08 will require companies to apply the definition of a performance obligation under ASC Topic 606 to recognize and measure contract assets and contract liabilities (i.e., deferred revenue) relating to contracts with customers that are acquired in a business combination. Under current U.S. GAAP, an acquirer generally recognizes assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU No. 2021-08 will result in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC Topic 606. ASU No. 2021-08 is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We are currently evaluating the impact of this ASU on our financial statements.

On June 30, 2022, the FASB issued ASU 2022-03 Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions ("ASU 2022-03"), which (1) clarifies the guidance in ASC 820 on the fair value measurement of an equity security that is subject to a contractual sale restriction and (2) requires specific disclosures related to such an equity security. Under current guidance, stakeholders have observed diversity in practice related to whether contractual sale restrictions should be considered in the measurement of the fair value of equity securities that are subject to such restrictions. On the basis of interpretations of existing guidance and the current illustrative example in ASC 820-10-55-52 of a restriction on the sale of an equity instrument, some entities use a discount for contractual sale restrictions when measuring fair value, while others view the application of such a discount to be inconsistent with the principles of ASC 820. To reduce the diversity in practice and increase the comparability of reported financial information, ASU 2022-03 clarifies this guidance and amends the illustrative example. ASU No. 2022-03 is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently evaluating the impact of this ASU on our financial statements.

The Company does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.

NOTE 3 – DISCONTINUED OPERATIONS

Due to the on-going losses and risk associated with the SmartDesk business the Company has valued the royalty and SAFE agreement associated with the SmartDesk sale at $0 and considers such consideration to be a gain contingency.

Based on sales projections for Cemtrex XR, Inc., the Company does not believe that it will exceed the sales levels required to exceed the $820,000 royalties due and has not accounted for any additional royalties at this time. In accordance with *ASC 310 – Receivables,* the Company has discounted the royalties due and has recognized $660,621 of royalties due and will amortize the remaining amount over the period the royalties are due.

The following table summarizes the loss on the sale:

---

| | |
|:---|:---|
| Purchase Price | $745621 |
| Less cash and cash equivalents transferred | (699423) |
| Less Liabilities assumed | (10924) |
| Net purchase price | $35274 |
| Assets Sold |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | $625638 |
| &nbsp;&nbsp;&nbsp;Inventory, net | 980730 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | 502577 |
| &nbsp;&nbsp;&nbsp;Property and equipment, net | 837808 |
| &nbsp;&nbsp;&nbsp;Goodwill | 598392 |
|  | 3545145 |
| Liabilities Transferred |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | 370774 |
| &nbsp;&nbsp;&nbsp;Short-term liabilities | 364775 |
| &nbsp;&nbsp;&nbsp;Long-term liabilities | 318981 |
|  | 1054530 |
| Net assets sold | $2490615 |
| Pretax loss on sale of Cemtrex Advanced Technologies, Inc, and Cemtrex XR, Inc.Companies | $(2455341) |

---

Assets and liabilities included within discontinued operations on the Company's Condensed Consolidated Balance Sheets at December 31, 2022 and September 30, 2022 are as follows;

SCHEDULE OF ASSETS AND LIABILITIES INCLUDED WITHIN DISCONTINUED OPERATIONS

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2022** | **September 30,**<br>**2022** |
| **Assets** |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;Cash and equivalents | $&nbsp;&nbsp;&nbsp;&nbsp; - | $714420 |
| &nbsp;&nbsp;&nbsp;Trade receivables, net |  | 561470 |
| &nbsp;&nbsp;&nbsp;Inventory –net of allowance for inventory obsolescence |  | 1043865 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | - | 153461 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets |  | 2473216 |
| Property and equipment, net |  | 825850 |
| Other | - | 672627 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Assets** | $**-** | $**3971693** |
| **Liabilities** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $- | $205622 |
| &nbsp;&nbsp;&nbsp;Short-term liabilities |  | 464429 |
| &nbsp;&nbsp;&nbsp;Deposits from customers |  | 125032 |
| &nbsp;&nbsp;&nbsp;Accrued expenses |  | 10136 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities |  | 805219 |
| Long-term liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Deferred revenue |  | 6273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | - | 6273 |
| &nbsp;&nbsp;&nbsp;**Total liabilities** | $**-** | $**811492** |

---

Loss from discontinued operations, net of tax and the loss on sale of discontinued operations, net of tax, of Cemtrex Advanced Technologies, Inc. and Cemtrex XR, Inc., sold during the first quarter of fiscal year 2023, which are presented in total as discontinued operations, net of tax in the Company's Condensed Consolidated Statements of Operations for the three-month periods ended December 31, 2022 and 2021, are as follows:

---

| | | |
|:---|:---|:---|
|  | Three months ended December 31, | Three months ended December 31, |
|  | 2022 | 2021 |
| Total net sales | $649061 | $1259904 |
| Cost of sales | 228086 | 612150 |
| Operating, selling, general and administrative expenses | 1295572 | 1402961 |
| Other expenses | 3195 | 3034 |
| Income (loss) from discontinued operations | (877792) | (758241) |
| Amortization of discounted royalties | 4427 |  |
| Loss on sale of discontinued operations | (2455341) |  |
| Income tax provision | - | - |
| Discontinued operations, net of tax | (3328706) | (758241) |

---

During the quarter ended December 31, 2022, Vicon completed the closure of its discontinued operating entity Vicon Systems, Ltd. located in Israel. The Company received funds of $96,095, which at the time of operational closure were not guaranteed to be retrievable. The company paid $7,010 in consulting fees for assistance in retrieving these funds. The net amount of $89,085 is recognized on the Company's Condensed Consolidated Income Statement as part of the Loss on Discontinued Operations.

NOTE 4 – LOSS PER COMMON SHARE

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. For the three months ended December 31, 2022, and 2021, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:

SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER COMMON SHARE AS ANTI-DILUTIVE EFFECT

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | For the three months ended | For the three months ended | For the three months ended | For the three months ended |
|  | December 31, | December 31, | December 31, | December 31, |
|  | 2022 | 2022 | 2021 | 2021 |
| Warrants to purchase shares |  |  |  | 12399 |
| Options |  | 31654 |  | 27143 |

---

NOTE 5 – SEGMENT INFORMATION

During the first quarter of fiscal year 2023, The Company reorganized its reporting segments to be in line with its current structure. The Company reports and evaluates financial information for three current segments: Security segment, Industrial Services segment and the Corporate segment.

The following tables summarize the Company's segment information:

SCHEDULE OF SEGMENT INFORMATION

---

| | | | |
|:---|:---|:---|:---|
|  | **Three months ended December 31, 2022** | **Three months ended December 31, 2022** | **Three months ended December 31, 2022** |
|  | **Security** | **Industrial<br> Services** | **Corporate** |
| Revenues | $7004744 | $4965498 | $- |
| Cost of revenues | 3601054 | 3326573 | - |
| &nbsp;&nbsp;&nbsp;Gross profit | $3403690 | $1638925 | $- |
| Operating expenses |  |  |  |
| &nbsp;&nbsp;&nbsp;Sales, general, and administrative | 2749429 | 1188865 | 986709 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 331155 | 167521 | 32154 |
| &nbsp;&nbsp;&nbsp;Research and development | 1538218 | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating loss | $(1215112) | $282539 | $(1018863) |
| Other income/(expense) | $(112399) | $(31560) | $(1001358) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Three months ended December 31, 2021** | **Three months ended December 31, 2021** | **Three months ended December 31, 2021** |
|  | **Security** | **Industrial Services** | **Corporate** |
| Revenues | $4359423 | 5053972 | $- |
| Cost of revenues | 2567358 | 3623787 | - |
| &nbsp;&nbsp;&nbsp;Gross profit | $1792065 | $1430185 | $- |
| Operating expenses |  |  |  |
| &nbsp;&nbsp;&nbsp;Sales, general, and administrative | 2859964 | 1410861 | 929423 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 31778 | 179223 | 36702 |
| &nbsp;&nbsp;&nbsp;Research and development | 1072898 | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating loss | $(2172575) | $(159899) | $(966125) |
| Other income/(expense) | $861700 | $(51048) | $(1282918) |

---

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2022** | **September 30,**<br>**2022** |
| Identifiable Assets |  |  |
| &nbsp;&nbsp;&nbsp;Security | $17722829 | $12052177 |
| &nbsp;&nbsp;&nbsp;Industrial Services | 17382118 | 16658984 |
| &nbsp;&nbsp;&nbsp;Corporate | 5802342 | 13077101 |
| &nbsp;&nbsp;&nbsp;Discontinued operations | 2327 | 3969366 |
| Total Assets | $40909616 | $45757628 |

---

NOTE 6 – RESTRICTED CASH

A subsidiary of the Company participates in a consortium in order to self-insure group care coverage for its employees. The plan is administrated by Benecon Group and the Company makes monthly deposits in a trust account to cover medical claims and any administrative costs associated with the plan. These funds, as required by the plan are restricted in nature and amounted to $1,601,723 at December 31, 2022 and $1,577,915 at September 30, 2022.

NOTE 7 – FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:

Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include cash equivalents, banker's acceptances, trading securities investments and investment funds. We measure trading securities investments and investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions.

Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified contractual term, a Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee's ability to continue as a going concern.

The Company's fair value assets at December 31, 2022 and September 30, 2022, are as follows.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Quoted Prices<br>in Active<br>Markets for<br>Identical Assets<br>(Level 1) | Significant<br>Other<br>Observable<br>Inputs<br>(Level 2) |<br>Significant<br>Unobservable<br>Inputs<br>(Level 3) |<br>Balance<br>as of<br>December 31,<br>2022 |
| **Assets** |  |  |  |  |
| Investment in marketable securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;(included in short-term investments) | $13721 | $- | $- | $13721 |
|  | $13721 | $- | $- | $13721 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Quoted Prices<br>in Active<br>Markets for<br>Identical Assets<br>(Level 1) | Significant<br>Other<br>Observable<br>Inputs<br>(Level 2) |<br>Significant<br>Unobservable<br>Inputs<br>(Level 3) |<br>Balance<br>as of<br>September 30,<br>2022 |
| **Assets** |  |  |  |  |
| Investment in marketable securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;(included in short-term investments) | $13721 | $- | $- | $13721 |
|  | $13721 | $- | $- | $13721 |

---

NOTE 8 – TRADE RECEIVABLES, NET

Trade receivables, net consist of the following:

SCHEDULE OF TRADE RECEIVABLES, NET

---

| | | |
|:---|:---|:---|
|  | December 31,<br>2022 | September 30,<br>2022 |
| Trade receivables | $7190026 | $5648655 |
| Allowance for doubtful accounts | (253949) | (249439) |
|  | $6936077 | $5399216 |

---

Trade receivables include amounts due for shipped products and services rendered.

Allowance for doubtful accounts includes estimated losses resulting from the inability of our customers to make the required payments.

NOTE 9 – INVENTORY, NET

Inventory, net, consist of the following:

SCHEDULE OF INVENTORY, NET

---

| | | |
|:---|:---|:---|
|  | December 31,<br>2022 | September 30,<br>2022 |
| Raw materials | $1420041 | $1375933 |
| Work in progress | 105076 | 120026 |
| Finished goods | 8178978 | 8080235 |
|  | 9704095 | 9576194 |
| Less: Allowance for inventory obsolescence | (1099336) | (1088377) |
| Inventory –net of allowance for inventory obsolescence | $8604759 | $8487817 |

---

NOTE 10 – PREPAID AND OTHER CURRENT ASSETS

On December 31, 2022, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $1,445,861, costs and estimated earnings in excess of billings on uncompleted contracts of $521,172, and other current assets of $1,125,585. On September 30, 2022, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $414,997, costs and estimated earnings in excess of billings on uncompleted contracts of $781,819, accrued income taxes refunds on foreign operations of $37,761, and prepaid expenses and other current assets of $1,187,067.

NOTE 11 – PROPERTY AND EQUIPMENT

Property and equipment are summarized as follows:

SUMMARY OF PROPERTY AND EQUIPMENT

---

| | | |
|:---|:---|:---|
|  | December 31,<br>2022 | September 30,<br>2022 |
| Land | $790373 | $790373 |
| Building and leasehold improvements | 2913851 | 2906953 |
| Furniture and office equipment | 552931 | 546548 |
| Computers and software | 376996 | 365892 |
| Machinery and equipment | 11270672 | 11242709 |
|  | 15904823 | 15852475 |
| Less: Accumulated depreciation | (10796556) | (10572033) |
| Property and equipment, net | $5108267 | $5280442 |

---

Depreciation expense for the three months ended December 31, 2022, and 2021 were $530,830, and $262,833, respectively.

NOTE 12 – OTHER ASSETS

As of December 31, 2022, the Company had other assets of $1,546,101which was comprised of rent security of $62,041, a strategic investment in MasterpieceVR of $1,000,000 (see below), and other assets of $484,060. As of September 30, 2022, the Company had other assets of $1,399,745 which was comprised of rent security deposits of $204,388, Investment in Masterpiece VR valued at $1,000,000, and other assets of $195,357.

On November 13, 2020, Cemtrex made a $500,000 investment and on January 19, 2022, made an additional $500,000 investment via a simple agreement for future equity ("SAFE") in MasterpieceVR. The SAFE provides that the Company will automatically receive shares of the entity based on the conversion rate of future equity rounds up to a valuation cap, as defined. MasterpieceVR is a software company that is developing software for content creation using virtual reality. The investment is included in other assets in the accompanying balance sheet and the Company accounts for this investment and recorded at cost. No impairment has been recorded for the quarter ended December 31, 2022.

NOTE 13 – RELATED PARTY TRANSACTIONS

On August 31, 2019, the Company entered into an Asset Purchase Agreement for the sale of Griffin Filters, LLC to Ducon Technologies, Inc., which Aron Govil, the Company's Founder and former CFO, for total consideration of $550,000. On July 31, 2022, the Company negotiated a payment agreement surrounding the sale of Griffin Filters, LLC and other liabilities due to Cemtrex, Inc. totaling $761,585. This agreement is in the form of a secured promissory note earning interest at a rate of 5% per annum and matures on July 31, 2024.

As of December 31, 2022, and September 30, 2022, there was $19,034 and $19,133 payable due to Ducon Technologies, Inc., respectively.

Receivables of $708,512 that represented the amount due from Ducon to Cemtrex Technologies Pvt. Ltd. the Company's subsidiary based in India were written off to bad debt in fiscal year 2022.

On February 26, 2021, the Company entered into a Settlement Agreement and Release with Aron Govil regarding transactions Cemtrex's Board of Directors determined were incorrectly handled and accounted for. Mr. Govil executed a secured promissory note (the "Note") in the amount of $1,533,280. The Note matures and is due in full in two years and bears interest at 9% per annum and is secured by all of Mr. Govil's assets. Mr. Govil also agreed to sign an affidavit confessing judgment in the event of a default on the Note. While the Company believes the note is fully collectible, in accordance with ASC 450-30, Gain Contingencies, the Company determined the gain will not be recognized until the note is paid. Accordingly, the note and associated gain is not presented on the Company's Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations.

On November 22, 2022, the Company entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity ("SAFE") with the Company's CEO, Saagar Govil, to secure the sale of the subsidiaries Cemtrex Advanced Technologies, Inc, and Cemtrex XR, Inc., which include the brands SmartDesk, Cemtrex XR, Virtual Driver Interactive, Bravo Strong, and good tech (formerly Cemtrex Labs), to Mr. Govil (see NOTE 1).

As of December 31, 2022, there was $383,710 in trade receivables due from these companies. $107,910 of these receivables are related to costs paid by Cemtrex related to payroll during the transition of employees to the new company. The remaining $275,800 are related to services provided by Cemtrex Technologies Pvt. Ltd. in the normal course of business.

As of December 31, 2022, there were royalties receivable from the sale of Cemtrex, XR, Inc. of $665,048.

NOTE 14 – LEASES

The Company is party to contracts where we lease property from others under contracts classified as operating leases. The Company primarily leases office and operating facilities, vehicles, and office equipment. The weighted average remaining term of our operating leases was approximately 3.6 years at December 31, 2022 and 4.3 years at December 31, 2021. Lease liabilities were $2,520,506 with $787,561classified as short-term at December 31, 2022, and $2,576,963 with $754,495, classified as short-term at September 30, 2022. The weighted average discount rate used to measure lease liabilities was approximately 5.6% at December 31, 2022 and 6.6% at December 31, 2021. The Company used the rate implicit in the lease, where known, or its incremental borrowing rate as the rate used to discount the future lease payments.

The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.

A reconciliation of undiscounted cash flows to operating lease liabilities recognized in the condensed consolidated balance sheet at December 31, 2022, is set forth below:

SCHEDULE OF RECONCILIATION OF UNDISCOUNTED CASH FLOWS TO OPERATING LEASE LIABILITIES

---

| | |
|:---|:---|
| Years ending September 30, | Operating Leases |
| 2023 | 667747 |
| 2024 | 755686 |
| 2025 | 733327 |
| 2026 | 539279 |
| 2027 & Thereafter | 205358 |
| &nbsp;&nbsp;&nbsp;Undiscounted lease payments | 2901397 |
| &nbsp;&nbsp;&nbsp;Amount representing interest | (380891) |
| &nbsp;&nbsp;&nbsp;Discounted lease payments | $2520506 |

---

Lease costs for the three months ended December 31, 2022 and 2021 are set forth below.:

SCHEDULE OF LEASE COSTS

---

| | | |
|:---|:---|:---|
|  | For the three months ended | For the three months ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
| Lease costs: |  |  |
| &nbsp;&nbsp;&nbsp;Finance lease costs | $- | $17272 |
| &nbsp;&nbsp;&nbsp;Operating lease costs | 261433 | 980062 |
| **Total lease cost** | $**261433** | $**997334** |

---

NOTE 15 – LINES OF CREDIT AND LONG-TERM LIABILITIES

The following table outlines the Company's lines of credit and liabilities.

SCHEDULE OF LINES OF CREDIT AND LIABILITIES

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | <br>**Interest Rate** | <br>**Maturity** | **December 31,**<br>**2022** | **September 30,**<br>**2022** |
| Fulton Bank line of credit $3,500,000 - The terms of this line of credit are subject to the bank's review annually on February 1. | Secured Overnight Financing Rate ("SOFR") plus 2.37% (6.67% as of December 31, 2022 and 5.35% as of September 30, 2022) | N/A | $- | $- |
| Fulton Bank loan $5,250,000 for the purchase of AIS $5,000,000 of the proceeds went to the direct purchase of AIS. This loan is secured by certain assets of the Company. | SOFR plus 2.37%(6.67% as of December 31, 2022 and 5.35% as of September 30, 2022) | 12/15/2022 |  | 247284 |
| Fulton Bank loan $400,000 fund equipment for AIS. The Company was in compliance with loan covenants as of December 31, 2022. This loan is secured by certain assets of the Company. | SOFR plus 2.37% (6.67% as of December 31, 2022 and 5.35% as of September 30, 2022) | 5/1/2023 | 39843 | 63280 |
| Fulton Bank - $360,000 fund equipment for AIS. The Company was in compliance with loan covenants as of December 31, 2022. This loan is secured by certain assets of the Company. | SOFR plus 2.37% (6.67% as of December 31, 2022 and 5.35% as of September 30, 2022). | 5/1/2023 | 165518 | 183839 |
| Fulton Bank mortgage $2,476,000. The Company was in compliance with loan covenants as of December 31, 2022. | SOFR plus 2.62% (6.92% as of December 31, 2022 and 5.6% as of September 30, 2022). | 1/28/2040 | 2228157 | 2245664 |
| Note payable - $439,774. For the purchase of VDI. Payable in two installments on October 26, 2021, and October 26, 2022. | 5% | 10/26/2022 |  | 219370 |
| Note payable - $5,755,000 - Less original issue discount $750,000 and legal fees $5,000, net cash received $5,000,000 Unamortized original issue discount balance of $125,000 and $250,000, as of December 31, 2022 and September 30, 2022respectively. | 8% | 3/30/2023 | 4921279 | 4943929 |
| Note payable - $9,205,000. Less original issue discount $1,200,000 and legal fees $5,000,net cash received $8,000,000. 28,572 shares of common stock valued at $700,400 recognized as additional original issue discount. Unamortized original issue discount balance of $739,044 and$1,064,778 as of December 31, 2022 and September 30, 2022 respectivly. | 8% | 8/23/2023 | 10089381 | 9738632 |
| Term Loan Agreement with NIL Funding Corporation ("NIL") - $5,600,000 The Company was in compliance with loan covenants as of December 31, 2022. | 8.85% | 3/30/2023 | 2729743 | 2804743 |
| Paycheck Protection Program loan - $121,400 - The issuing bank determined that this loan qualifies for loan forgiveness; however the Company is awaiting final approval from the Small Business Administration. |  | 5/5/2025 | 121400 | 121400 |
| **Total Notes Payable** |  |  | $**20295321** | $**20568141** |
| &nbsp;&nbsp;&nbsp;Less: Current maturities |  |  | (17099485) | (16894743) |
| **Notes Payable, Long Term** |  |  | $**3195836** | $**3673398** |

---

NOTE 16 – SHAREHOLDERS' EQUITY

*Preferred Stock*

 

The Company is authorized to issue 10,000,000 shares of Preferred Stock, $0.001 par value. As of December 31, 2022, and September 30, 2022, there were 2,233,463 and 2,129,122 shares issued and 2,169,363 and 2,065,022 shares outstanding, respectively.

 

Series 1 Preferred Stock

During the three months ended December 31, 2022, 104,341 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

As of December 31, 2022, and September 30, 2022, there were 2,183,463 and 2,079,122 shares of Series 1 Preferred Stock issued and 2,119,363 and 2,015,022 shares of Series 1 Preferred Stock outstanding, respectively.

Series C Preferred Stock

As of December 31, 2022, and September 30, 2022, there were 50,000 shares of Series C Preferred Stock issued and outstanding.

*Common Stock*

 

On January 25, 2023, the Company completed a 35:1 reverse stock split on its common stock. All share and per share data have been retroactively adjusted for this reverse split.

The Company is authorized to issue 50,000,000 shares of common stock, $0.001 par value. As of December 31, 2022, there were 793,727 shares issued and outstanding and at September 30, 2022, there were 754,711 shares issued and outstanding.

During the three months ended December 31, 2022, 39,016 shares of the Company's common stock have been issued to satisfy $31,331 of notes payable, $168,669 in accrued interest, and $32,145 of excess value of shares issued recorded as interest expense.

NOTE 17 – SHARE-BASED COMPENSATION

For the three months ended December 31, 2022, and 2021, the Company recognized $39,842 and $45,371 of share-based compensation expense on its outstanding options, respectively. As of December 31, 2022, $152,433 of unrecognized share-based compensation expense is expected to be recognized over a period of four years. Future compensation amounts will be adjusted for any change in estimated forfeitures.

During the three months ended December 31, 2022, options to purchase 2,931 shares of the Company's common stock at an exercise price of $13.65 per share were cancelled.

NOTE 18 – COMMITMENTS AND CONTINGENCIES

The Company has its corporate headquarters in New York City with a 12-month lease of 2,500 square feet of office space at a rate of $10,000 per month expiring on February 28, 2023.

The Company's Industrial Services segment owns approximately 25,000 square feet of warehouse space in Manchester, PA and approximately 43,000 square feet of office and warehouse space in York, PA. The IS segment also leases approximately 15,500 square feet of warehouse space in Emigsville, PA from a third party in a three-year lease at a monthly rent of $4,555 expiring on August 31, 2025.

The Company's Security segment leases (i) approximately 6,700 square feet of office and warehouse space in Pune, India from a third party in an five year lease at a monthly rent of $6,453 (INR456,972) expiring on February 28, 2024, (ii) approximately 30,000 square feet of office and warehouse space in Hauppauge, New York from a third party in a seven-year lease at a monthly rent of $28,719 expiring on March 31, 2027, and (iii) approximately 9,400 square feet of office and warehouse space in Hampshire, England in a fifteen-year lease with at a monthly rent of $7,329 (£5,771) which expires on March 24, 2031 and contains provisions to terminate in 2026.

NOTE 19 – SUBSEQUENT EVENTS

*Reverse Stock Split*

 

On January 25, 2023, the company completed a 35:1 reverse stock split on its common stock. All share and per share data have been retroactively adjusted for this reverse split.

*Extension of cure period*

 

On January 26, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that, it had been granted an additional 180 days or until July 24, 2023, to regain compliance with the Minimum Bid Price Requirement on its Series 1 Preferred stock.

*Listing Rule Compliance*

On February 8, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that it has regained compliance with Listing Rule 5550(a)(2) and is in compliance with all applicable listing standards. The Company's common stock will continue to be listed and traded on The Nasdaq Stock Market. The hearing scheduled for March 16, 2023 before the Hearings Panel has been cancelled.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as "anticipates", "believes", "could", "estimates", "expects", "may", "plans", "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and their pricing; unexpected manufacturing or supplier problems; the Company's ability to maintain sufficient credit arrangements; changes in governmental standards by which our environmental control products are evaluated and the risk factors reported from time to time in the Company's SEC reports, including its recent report on Form 10-K. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.*

**General Overview**

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. The currently operates in two areas: industrial services, and intelligent security systems. Unless the context requires otherwise, all references to "we", "our", "us", "Company", "registrant", "Cemtrex" or "management" refer to Cemtrex, Inc. and its subsidiaries.

During the first quarter of fiscal year 2023, The Company reorganized its reporting segments to be in line with its current structure. The Company has three business segments, consisting of (i) Security (ii) Industrial Services and (iii) Cemtrex Corporate.

*Security* 

Cemtrex's Security segment operates under the Vicon Industries brand. Vicon Industries, a majority owned subsidiary, provides end-to-end security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon's products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

*Industrial Services*

Cemtrex's Industrial Services segment operates under the brand, Advanced Industrial Services ("AIS"), that offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals among others. We are a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

*Cemtrex Corporate*

Cemtrex's Corporate segment is the holding company of our other two segments.

 

**Significant Accounting Policies and Estimates** 

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

Certain of our accounting policies are deemed "significant", as they are both most important to the financial statement presentation and require management's most difficult, subjective or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our significant accounting policies, see "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended September 30, 2022.

**Results of Operations – For the three months ending December 31, 2022, and 2021**

Total revenue for the three months ended December 31, 2022, and 2021 was $11,970,242 and $9,413,395, respectively, an increase of $2,556,847, or 27%. Loss from continuing operations for the three months ended December 31, 2022, was $3,096,753 compared to $3,770,865 for the three months ended December 31, 2021, a decrease on the loss of $674,112, or 18%. Total revenue for the quarter increased, as compared to total revenue in the same period last year, due to increased demand for the Company's products and services. Loss from operations decreased due to increased revenues as compared to the same period in the prior year.

*Revenues*

Our Security segment revenues for the three months ended December 31, 2022, increased by $2,646,131 or 40% to $7,004,744 from $4,358,613 for the three months ended December 31, 2021. This increase is due to an increased demand for Security technology.

Our Industrial Services segment revenues for the three months ended December 31, 2022, decreased by $88,474 or 2%, to $4,965,498 from $5,053,972 for the three months ended December 31, 2021. This decrease is mainly due to timing of the recognition of revenue for the segment's products and services.

*Gross Profit* 

Gross Profit for the three months ended December 31, 2022, was $5,042,615 or 42% of revenues as compared to gross profit of $3,222,250 or 34% of revenues for the three months ended December 31, 2021.

Gross profit in our Security segment was $3,403,690 or 49% of the segment's revenues for the three months ended December 31, 2022 as compared to gross profit of $1,791,255 or 41% of the segment's revenues for the period ended December 31, 2021. Gross profit as a percentage of revenues increased in the three months ended December 31, 2022, compared to the three months ended December 31, 2021, due to price increases implemented throughout the segment in response to rising costs of our goods and transportation costs.

Gross profit in our Industrial Services segment was $1,638,925 or 33% of the segment's revenues for the three months ended December 31, 2022 as compared to gross profit of $1,430,185 or 28% of the segment's revenues for the period ended December 31, 2021. Gross profit as a percentage of revenues increased in the three months ended December 31, 2022, compared to the three months ended December 31, 2021, was primarily due to lower subcontractor costs.

 

*General and Administrative Expenses*

General and administrative expenses for the three months ended December 31, 2022, increased $7,882 or 0.14% to $5,455,833 from $5,447,951 for the three months ended December 31, 2021. General and administrative expenses as a percentage of revenues were 46% and 58% of revenues for the three-month periods ended December 31, 2022, and 2021, respectively.

*Research and Development Expenses*

Research and Development expenses for the three months ended December 31, 2022, were $1,538,218 compared to $1,072,898 for the three months ended December 31, 2021. Research and Development expenses are primarily related to the Security Segment's development of next generation solutions associated with security and surveillance systems software.

 

*Other Income/(Expense)*

Other income/(expense) for the first quarter of fiscal 2022, was an expense of $1,145,317 as compared to an expense of $472,266 for the first quarter of fiscal 2021. Other income/(expense) for the three months ended December 31, 2022, was mainly driven by interest on the Company's debt. Other income/(expense) for the three months ended December 31, 2021, included the gain on the forgiveness of our PPP loans of $971,500.

*Provision for Income Taxes*

 

During the first quarters of fiscal 2022, and 2021, the Company took no provision on income taxes. The provision for income tax is based upon the projected income tax from the Company's various U.S. and international subsidiaries that are subject to their respective income tax jurisdictions and the Company's projected ability to utilize net loss carryforwards.

*Loss from Discontinued Operations*

 

As discussed in Note 3, the Company had losses on discontinued operations of $3,239,621. The losses are comprised of the $2,455,701 loss on the sale of Cemtrex Advanced Technologies, and Cemtrex XR, Inc.. The net loss of $877,792 for the three months ended December 31, 2022, and the net gain on the recovery of cash from Vicon Industries Ltd. of $89,085. Losses on discontinued operations for the three months ended December 31, 2021 were $758,241 attributable to the operations of the Cemtrex brands discussed in Note 3.

*Net income/(loss) attributable to Cemtrex, Inc. shareholders*

 

The Company had a net loss attributable to Cemtrex, Inc. shareholders of $6,277,711, or 52% of revenues, for the three-month period ended December 31, 2022, as compared to net loss attributable to Cemtrex, Inc. shareholders of $4,477,951 or 42% of revenues, for the three months ended December 31, 2021. The net loss attributable to Cemtrex, Inc. shareholders increased in the first quarter as compared to the same period last year was primarily due to the loss on discontinued operations.

**Effects of Inflation**

The Company's business and operations have not been materially affected by inflation during the periods for which financial information is presented.

**Liquidity and Capital Resources**

Working capital deficit was $469,270 at December 31, 2022, compared to working capital of $4,754,493 at September 30, 2022. This includes cash and equivalents and restricted cash of $7,370,333 at December 31, 2022, and $12,188,096 at September 30, 2022. The decrease in working capital was primarily due to the Company's transfer of cash to in the sale of Cemtrex Advanced Technologies and Cemtrex XR, Inc. and accrual of interest on short-term liabilities during the first quarter of fiscal year 2023.

Cash used by operating activities for continuing operations for the three months ended December 31, 2022 and 2021 was $5,872,310 and $3,633,702 respectively. Cash provided by operating activities for discontinued operations for the three months ended December 31, 2022 was $2,501,426, compared to using cash of $719,237. The increase in operating cash usage for continuing operations was primarily due to increases of trade receivables, prepaid expenses, and other assets and payment of accounts payable and other liabilities.

Trade receivables increased $1,536,861 or 28% to $6,936,077 at December 31, 2022, from $5,399,216 at September 30, 2022. The increase in trade receivables is attributable to increased sales in the Security segment.

Inventories increased $116,492 or 1% to $8,604,759 at December 31, 2022, from $8,487,817 at September 30, 2022. The increase in inventories is attributable to inventories in transit yet to be sold.

Cash used by investment activities for continuing operations for the three months ended December 31, 2022 was $568,111 compared to $291,666 for the three-month period ending December 31, 2021. Cash provided by investing activities for discontinued operations for the three months ended December 31, 2022 was $207,329. Investing activities for the first quarter of fiscal year 2023 were driven mainly by the Company's purchase of property and equipment.

Cash used by financing activities for the three months ended December 31, 2022, was $600,920 compared to $632,753 for the three-month period ending December 31, 2021. Financing activities were primarily driven by payments on the Company's debt and the royalties receivable for discontinued operations.

While our working capital deficit and current debt indicate a substantial doubt regarding the Company's ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. Additionally, the Company has recently sold unprofitable brands, reducing the cash required to maintain those brands, reevaluated our pricing model on our Vicon brand to improve margins on those products, and has effected a reverse stock split on our common stock to remain trading on the Nasdaq Capital Markets, and improved our ability to potentially raise capital through equity offerings that we may use to satisfy debt. In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans are sufficient to meet the capital demands of our current operations for at least the next twelve months, the is no guarantee that we will succeed.

Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. We currently do not have adequate cash to meet our short or long-term needs. The consolidated financial statements do not include any adjustments relating to this uncertainty.

**Item 4. Controls and Procedures** 

**Evaluation of Disclosure Controls and Procedures** 

Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2022. Based on their evaluation, our management has concluded that as of December 31, 2022, our disclosure controls and procedures were not effective and there is a material weakness in our internal control over financial reporting. The material weakness relates to the Company lacking sufficient accounting personnel. The shortage of accounting personnel resulted in the Company lacking entity level controls around the review of period-end reporting processes, accounting policies and public disclosures. Additionally, the Company's current processes and systems do not provide for necessary, timely reconciliation of certain accounts and sufficient consideration regarding recoverability of certain assets. This deficiency is common in small companies, similar to us, with limited personnel.

Notwithstanding the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures as of December 31, 2022, were not effective, and notwithstanding the material weakness in our internal control over financial reporting described below, management believes that the unaudited condensed financial statements and related financial information included in this Quarterly Report fairly present in all material respects our financial condition, results of operations and cash flows as of the dates presented, and for the periods ended on such dates, in conformity with GAAP.

In order to mitigate the material weaknesses, the Company has implemented measures that they believe have mitigated these weaknesses but has not had sufficient time to fully evaluate these measures. These measures include; (i) updating our accounting software to ensure tighter control over entries and providing improved data for timely reconciliation of certain accounts, and (ii) engaged a third-party accounting firm to provide review of period-end reporting processes, accounting policies and public disclosures.

**Changes in Internal Control Over Financial Reporting** 

While there was no change in the Company's internal control over financial reporting during the Company's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting, the Company is continuing to improve its internal controls through the actions mentioned above.

**Limitations on the Effectiveness of Controls**

Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

**<u>Part II Other Information</u>**

**Item 1. Legal Proceedings.**

NONE.

**Item 1A. Risk Factors**

See Risk Factors included in our Annual Report on Form 10-K for 2022.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

During the three months ended December 31, 2022, 39,016 shares of the Company's common stock have been issued to satisfy $31,331 of notes payable, $168,669 in accrued interest, and $32,145 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

**Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 2.2 | [Stock Purchase Agreement regarding the stock of Advanced Industrial Services, Inc., AIS Leasing Company, AIS Graphic Services, Inc., and AIS Energy Services, LLC, Dated December 15, 2015. (8)](https://www.sec.gov/Archives/edgar/data/1435064/000114420416125292/v449407_ex10-1.htm) |
| 3.1 | [Certificate of Incorporation of the Company.(1)](https://www.sec.gov/Archives/edgar/data/1435064/000114420408031792/v115603_ex3-1.htm) |
| 3.2 | [By Laws of the Company.(1)](https://www.sec.gov/Archives/edgar/data/1435064/000114420408031792/v115603_ex3-2.htm) |
| 3.3 | [Certificate of Amendment of Certificate of Incorporation, dated September 29, 2006.(1)](https://www.sec.gov/Archives/edgar/data/1435064/000114420408031792/v115603_ex3-3.htm) |
| 3.4 | [Certificate of Amendment of Certificate of Incorporation, dated March 30, 2007.(1)](https://www.sec.gov/Archives/edgar/data/1435064/000114420408031792/v115603_ex3-4.htm) |
| 3.5 | [Certificate of Amendment of Certificate of Incorporation, dated May 16, 2007.(1)](https://www.sec.gov/Archives/edgar/data/1435064/000114420408031792/v115603_ex3-5.htm) |
| 3.6 | [Certificate of Amendment of Certificate of Incorporation, dated August 21, 2007.(1)](https://www.sec.gov/Archives/edgar/data/1435064/000114420408031792/v115603_ex3-6.htm) |
| 3.7 | [Certificate of Amendment of Certificate of Incorporation, dated April 3, 2015.(3)](https://www.sec.gov/Archives/edgar/data/1435064/000114420416120562/v447483_ex3-1.htm) |
| 3.8 | [Certificate of Designation of the Series A Preferred Shares, dated September 8, 2009.(2)](https://www.sec.gov/Archives/edgar/data/1435064/000114420409047901/v160150_ex4-1.htm) |
| 3.9 | [Certificate of Designation of the Series 1 Preferred Stock.(11)](https://www.sec.gov/Archives/edgar/data/1435064/000149315217000757/ex3-1.htm) |
| 3.10 | [Certificate of Amendment of Certificate of Incorporation, dated September 7, 2017 (12)](https://www.sec.gov/Archives/edgar/data/1435064/000149315217010368/ex3-1.htm) |
| 3.11 | [Certificate of Correction to the Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Cemtrex, Inc (6)](https://www.sec.gov/Archives/edgar/data/1435064/000149315219009062/ex3-1.htm) |
| 3.12 | [Amended Certificate of Designation of the Series 1 Preferred Shares, dated March 30, 2020.(16)](https://www.sec.gov/Archives/edgar/data/1435064/000149315220005636/ex3-1.htm) |
| 3.13 | [Certificate of Amendment of Certificate of Incorporation, dated July 29, 2020 (20)](https://www.sec.gov/Archives/edgar/data/1435064/000149315221000157/ex3-14.htm) |
| 3.14 | [Certificate of Correction of Certificate of Incorporation, dated July 29, 2021, filed October 7, 2020 (9)](https://www.sec.gov/Archives/edgar/data/1435064/000149315221013214/ex3-15.htm) |
|  | [Certificate of Amendment of Certificate of Incorporation, dated January 12, 2023 (7)](https://www.sec.gov/Archives/edgar/data/1435064/000149315223001986/ex3-1.htm) |
| 4.1 | [Form of Subscription Rights Certificate. (10)](https://www.sec.gov/Archives/edgar/data/1435064/000114420416121822/v447892_ex4-1.htm) |
| 4.2 | [Form of Series 1 Preferred Stock Certificate. (10)](https://www.sec.gov/Archives/edgar/data/1435064/000149315216015445/ex4-2.htm) |
| 4.3 | [Form of Series 1 Warrant. (10)](https://www.sec.gov/Archives/edgar/data/1435064/000149315216015696/ex4-3.htm) |
| 4.4 | [Form of Common Stock Purchase Warrant, dated March 22, 2019. (14)](https://www.sec.gov/Archives/edgar/data/1435064/000149315219003792/ex4-1.htm) |
| 10.1 | [Amendment of the Term Loan Agreement between Vicon and NIL Funding, dated March 4, 2020.(17)](https://www.sec.gov/Archives/edgar/data/1435064/000149315220003606/ex10-1.htm) |
| 10.2 | [Consulting Agreement, dated April 22, 2020 between Centrex, Inc. and Adtron, Inc. (5)](https://www.sec.gov/Archives/edgar/data/1435064/000149315220007479/ex10-1.htm) |
| 10.3 | [Securities Purchase Agreement dated June 1, 2020 (18)](https://www.sec.gov/Archives/edgar/data/1435064/000149315220010565/ex10-1.htm) |
| 10.4 | [Securities Purchase Agreement dated June 9, 2020 (19)](https://www.sec.gov/Archives/edgar/data/1435064/000149315220011103/ex10-1.htm) |
| 10.5 | [Settlement Agreement and Release between Cemtrex, Inc. and Aron Govil dated February 26, 2021 (13)](https://www.sec.gov/Archives/edgar/data/1435064/000149315221004996/ex10-1.htm) |
| 10.6 | [Securities Purchase Agreement dated February 22, 2022 (15)](https://www.sec.gov/Archives/edgar/data/1435064/000149315222013876/ex10-6.htm) |
| 10.7 | [Amendment of the Term Loan Agreement between Vicon and NIL Funding, dated March 30, 2022. (15)](https://www.sec.gov/Archives/edgar/data/1435064/000149315222013876/ex10-7.htm) |
| 10.8 | [Asset Purchase agreement between Cemtrex, Inc. and Saagar Govil, dated November 22, 2022 (22)](https://www.sec.gov/Archives/edgar/data/1435064/000149315222033890/ex10-1.htm) |
| 10.9 | [Asset Purchase agreement between Cemtrex, Inc. and Saagar Govil, dated November 22, 2022 (22)](https://www.sec.gov/Archives/edgar/data/1435064/000149315222033890/ex10-2.htm) |
| 10.10 | [Simple Agreement for Future Equity (SAFE) between Cemtrex, Inc. and Saagar Govil, dated November 18, 2022 (22)](https://www.sec.gov/Archives/edgar/data/1435064/000149315222033890/ex10-3.htm) |
| 14.1 | [Corporate Code of Business Ethics.(4)](https://www.sec.gov/Archives/edgar/data/1435064/000114420416111105/v443520_ex14-1.htm) |
| 21.1\* | [Subsidiaries of the Registrant](ex21-1.htm) |
| 31.1\* | [Certification of Chief Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm) |
| 31.2\* | [Certification of Interim Chief Financial Officer and Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm) |
| 32.1\* | [Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.](ex32-1.htm) |
| 32.2\* | [Certification of Interim Chief Financial Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.](ex32-2.htm) |
| 99.1 | [Order pursuant to Section 8A of the Securities Act – dated September 30, 2022. (21)](https://www.sec.gov/Archives/edgar/data/1435064/000149315222027577/ex99-1.htm) |
| 101.INS\* | Inline XBRL Instance Document |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

---

| | |
|:---|:---|
| \* | Filed herewith |
| 1 | Incorporated by reference from Form 10-12G filed on May 22, 2008. |
| 2 | Incorporated by reference from Form 8-K filed on September 10, 2009. |
| 3 | Incorporated by reference from Form 8-K filed on August 22, 2016. |
| 4 | Incorporated by reference from Form 8-K filed on July 1, 2016. |
| 5 | Incorporated by reference from Form S-8 filed on May 1, 20120 |
| 6 | Incorporated by reference from Form 8-K filed on June 12, 2019. |
| 7 | Incorporated by reference from Form 8-K filed on January 20, 2023. |
| 8 | Incorporated by reference from Form 8-K/A filed on September 26, 2016. |
| 9 | Incorporated by reference from Form 10-Q filed on May 28, 2021. |
| 10 | Incorporated by reference from Form S-1 filed on August 29, 2016 and as amended on November 4, 2016, November 23, 2016, and December 7, 2016. |
| 11 | Incorporated by reference from Form 8-K filed on January 24, 2017. |
| 12 | Incorporated by reference from Form 8-K filed on September 8, 2017. |
| 13 | Incorporated by reference from Form 8-K filed on February 26, 2021. |
| 14 | Incorporated by reference from Form 8-K filed on March 22, 2019. |
| 15 | Incorporated by reference from Form 10-Q filed on May 16, 2022. |
| 16 | Incorporated by reference from Form 8-K filed on April 1, 2020. |
| 17 | Incorporated by reference from Form 8-K filed on March 9, 2020. |
| 18 | Incorporated by reference from Form 8-K filed on June 4, 2020. |
| 19 | Incorporated by reference from Form 8-K filed on June 12, 2020. |
| 20 | Incorporated by reference from Form 10-K filed on January 5, 2021. |
| 21 | Incorporated by reference from Form 8-K filed on October 4, 2022. |
| 22 | Incorporated by reference from Form 8-K filed on November 29, 2022. |

---

**Signatures**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | Cemtrex, Inc. | Cemtrex, Inc. |
| Dated: | February 14, 2023 | By: | */s/ Saagar Govil* |
|  |  |  | Saagar Govil |
|  |  |  | Chief Executive Officer |
| Dated: | February 14, 2023 |  | */s/ Paul J. Wyckoff* |
|  |  |  | Paul J. Wyckoff |
|  |  |  | Interim Chief Financial Officer |
|  |  |  | and Principal Financial Officer |

---

## Exhibit 21.1

**EXHIBIT 21.1**

---

| | | | |
|:---|:---|:---|:---|
| **Name of consolidated**<br>**subsidiary or entity** | **State or other jurisdiction of**<br>**incorporation or organization** | **Date of incorporation or formation**<br>**(date of acquisition, if applicable)** | **Attributable**<br>**interest** |
| Advanced Industrial Services, Inc. | Pennsylvania | July 20, 1984 (December 15, 2015) | 100% |
| Cemtrex Technologies Pvt Ltd. | India | December 21, 2017 | 100% |
| Vicon Industries, Inc. | New York | March 23, 2018 | 95% |
| Vicon Industries Limited | United Kingdom | March 23, 2018 | 95% |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Saagar Govil, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I
 have reviewed this report on Form 10-Q of Cemtrex, Inc. and subsidiaries (the "registrant);

&nbsp;&nbsp;&nbsp;&nbsp;2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or
 omit to state a material fact necessary to make the statements made, in light of the circumstances
 under which such statements were made, not misleading with respect to the period covered
 by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based
 on my knowledge, the financial statements, and other financial information included in this
 report, fairly present in all material respects the financial condition, results of operations
 and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining
 disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
 and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
 and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures
 to be designed under our supervision, to ensure that material information relating to the
 registrant, including its consolidated subsidiaries, is made known to us by others within
 those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed
 such internal control over financial reporting, or caused such internal control over financial
 reporting to be designed under our supervision, to provide reasonable assurance regarding
 the reliability of financial reporting and the preparation of financial statements for external
 purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented
 in this report our conclusions about the effectiveness of the disclosure controls and procedures,
 as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed
 in this report any change in the registrant's internal control over financial reporting
 that occurred during the registrant's most recent fiscal quarter (the registrant's
 fourth fiscal quarter in the case of an annual report) that has materially affected, or is
 reasonably likely to materially affect, the registrant's internal control over financial
 reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The
 registrant's other certifying officer and I have disclosed, based on our most recent
 evaluation of internal control over financial reporting, to the registrant's auditors
 and the audit committee of the registrant's Board of Directors (or persons performing
 the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All
 significant deficiencies and material weaknesses in the design or operation of internal control
 over financial reporting which are reasonably likely to adversely affect the registrant's
 ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any
 fraud, whether or not material, that involves management or other employees who have a significant
 role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
|  | */s/ Saagar Govil* |
|  | Saagar Govil |
|  | Chief Executive Officer |
| Dated: February 14, 2023 |  |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Paul J. Wyckoff, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I
 have reviewed this report on Form 10-Q of Cemtrex, Inc. and subsidiaries (the "registrant);

&nbsp;&nbsp;&nbsp;&nbsp;2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or
 omit to state a material fact necessary to make the statements made, in light of the circumstances
 under which such statements were made, not misleading with respect to the period covered
 by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based
 on my knowledge, the financial statements, and other financial information included in this
 report, fairly present in all material respects the financial condition, results of operations
 and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining
 disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
 and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
 and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures
 to be designed under our supervision, to ensure that material information relating to the
 registrant, including its consolidated subsidiaries, is made known to us by others within
 those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed
 such internal control over financial reporting, or caused such internal control over financial
 reporting to be designed under our supervision, to provide reasonable assurance regarding
 the reliability of financial reporting and the preparation of financial statements for external
 purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented
 in this report our conclusions about the effectiveness of the disclosure controls and procedures,
 as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed
 in this report any change in the registrant's internal control over financial reporting
 that occurred during the registrant's most recent fiscal quarter (the registrant's
 fourth fiscal quarter in the case of an annual report) that has materially affected, or is
 reasonably likely to materially affect, the registrant's internal control over financial
 reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The
 registrant's other certifying officer and I have disclosed, based on our most recent
 evaluation of internal control over financial reporting, to the registrant's auditors
 and the audit committee of the registrant's Board of Directors (or persons performing
 the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All
 significant deficiencies and material weaknesses in the design or operation of internal control
 over financial reporting which are reasonably likely to adversely affect the registrant's
 ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any
 fraud, whether or not material, that involves management or other employees who have a significant
 role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
|  | */s/ Paul J. Wyckoff* |
|  | Paul J. Wyckoff |
|  | Interim Chief Financial Officer |
|  | and Principal Financial Officer |
| Dated: February 14, 2023 |  |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the quarterly report of Cemtrex, Inc. (the "Company") on Form 10-Q for the quarter ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Saagar Govil, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

&nbsp;&nbsp;&nbsp;&nbsp;(1) the
 Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
 Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;(2) the
 information contained in the Report fairly presents, in all material respects, the financial
 condition and result of operations of the Company.

---

| | |
|:---|:---|
|  | */s/ Saagar Govil* |
|  | Saagar Govil |
|  | Chief Executive Officer |
| Dated: February 14, 2023 |  |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the quarterly report of Cemtrex, Inc. (the "Company") on Form 10-Q for the quarter ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Paul J. Wyckoff, Interim Chief Financial Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

&nbsp;&nbsp;&nbsp;&nbsp;(1) the
 Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
 Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;(2) the
 information contained in the Report fairly presents, in all material respects, the financial
 condition and result of operations of the Company.

---

| | |
|:---|:---|
|  | */s/ Paul J. Wyckoff* |
|  | Paul J. Wyckoff |
|  | Interim Chief Financial Officer |
|  | and Principal Financial Officer |
| Dated: February 14, 2023 |  |

---